Showing results (1491-1500 of 6,507) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|July 2, 2024
Impact of fludarabine and treosulfan on ovarian tumor cells and mesothelin chimeric antigen receptor T cellsIbrahim El-Serafi, Isabella Micallef Nilsson, Alina Moter, et al.Cancer Immunology, Immunotherapy : CII|July 2, 2024
Tumor-intrinsic IFNα and CXCL10 are critical for immunotherapeutic efficacy by recruiting and activating T lymphocytes in tumor microenvironmentChun-Chia Cheng, Jungshan Chang, Ai-Sheng Ho, et al.Cancer Immunology, Immunotherapy : CII|November 1, 2023
Tumor-associated neutrophils upregulate PANoptosis to foster an immunosuppressive microenvironment of non-small cell lung cancerQin Hu, Runtian Wang, Jiaxin Zhang, et al.Cancer Immunology, Immunotherapy : CII|November 16, 2023
Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustionMussarat Wahid, Benjamart Pratoomthai, Isioma U Egbuniwe, et al.Cancer Immunology, Immunotherapy : CII|March 30, 2024
Lipid droplets-related Perilipin-3: potential immune checkpoint and oncogene in oral squamous cell carcinomaYijia He, Lingyun Liu, Yuexin Dong, et al.Cancer Immunology, Immunotherapy : CII|March 30, 2024
Efficacy of immune checkpoint inhibitors differs in various status of carcinoma: a study based on 29 cohorts with 3255 participantsChunlan Wu, Yujun Ke, Luying Wan, et al.Cancer Immunology, Immunotherapy : CII|March 30, 2024
IL7 in combination with radiotherapy stimulates a memory T-cell response to improve outcomes in HNSCC modelsJustin Yu, Jacob Gadwa, Richard B Ross, et al.Cancer Immunology, Immunotherapy : CII|March 30, 2024
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growthAndrew N Wilkinson, Rui Chen, Elaina Coleborn, et al.Cancer Immunology, Immunotherapy : CII|March 30, 2024
DR30318, a novel tri-specific T cell engager for Claudin 18.2 positive cancers immunotherapyZhe Ma, Zhenxing Zhou, Wenwen Duan, et al.Cancer Immunology, Immunotherapy : CII|March 27, 2024
Co-targeting CD47 and VEGF elicited potent anti-tumor effects in gastric cancerKaiqi Zhang, Yuan Xu, Xusheng Chang, et al.Pageof 651